Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?

Jie Hua1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Si Shi1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Dingkong Liang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Chen Liang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Qingcai Meng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Bo Zhang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Quanxing Ni1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]

Jin Xu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Xianjun Yu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.